The promotion of angiogenesis by growth factors integrated with ECM proteins through coiled-coil structures

Biomaterials

Volumn 34, Issue 13, 2013, Pages 3315-3323

  Assal, Yasmine ^a   Mie, Masayasu ^a   Kobatake, Eiry ^a  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Angiogenesis; Cell proliferation; Endothelial cell; Extracellular matrix (ECM); Growth factor; Scaffold

Indexed keywords

ANGIOGENESIS; BASIC FIBROBLAST GROWTH FACTOR; COILED COIL; COILED-COIL STRUCTURE; COLLAGEN BINDING DOMAIN; COUPLING METHODS; DIFFERENTIATED CELLS; ECM PROTEINS; EPIDERMAL GROWTH FACTORS; EXTRACELLULAR MATRICES; EXTRACELLULAR MATRIX PROTEIN; GROWTH FACTOR; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; NON-COVALENT; PROTEIN ENGINEERING; VASCULAR ENDOTHELIAL GROWTH FACTOR;

BIOLOGICAL MATERIALS; CELL PROLIFERATION; ENDOTHELIAL CELLS; GENETIC ENGINEERING; PROTEINS; SCAFFOLDS;

SCAFFOLDS (BIOLOGY);

COLLAGEN BINDING PROTEIN; ELASTIN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; HYBRID PROTEIN; LAMININ; SCLEROPROTEIN; VASCULOTROPIN;

ALPHA HELIX; AMINO ACID SEQUENCE; ANGIOGENESIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; COILED COIL STRUCTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN ENGINEERING; PROTEIN EXPRESSION; PROTEIN IMMOBILIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN STRUCTURE; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE REPAIR; UMBILICAL VEIN ENDOTHELIAL CELL;

ADSORPTION; BIOLOGICAL MARKERS; CELL ADHESION; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMOBILIZED PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT FUSION PROTEINS;

EID: 84874229786     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.01.067     Document Type: Article

References (30)

1. Carmeliet P. Angiogenesis in health and disease. Nature Medicine 2003, 9(6):653-660.
2. Li J., Zhang Y.P., Kirsner R.S. Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix. Microscopy Research and Technique 2003, 60(1):107-114.
3. Folkman J., Shing Y. Angiogenesis. The Journal of Biological Chemistry 1992, 267(16):10931-10934.
4. Nakamura M., Mie M., Mihara H., Kobatake E. Construction of multi-functional extracellular matrix proteins that promote tube formation of endothelial cells. Biomaterials 2008, 29(20):2977-2986.
5. Kobatake E., Onoda K., Yanagida Y., Aizawa M. Design and gene engineering synthesis of an extremely thermostable protein with biological activity. Biomacromolecules 2000, 1(3):382-386.
6. Karle I.L., Urry D.W. Crystal structure of cyclic (APGVGV)2, an analog of elastin, and a suggested mechanism for elongation/contraction of the molecule. Biopolymers 2005, 77(4):198-204.
7. Barrera D.A., Zylstra E., Lansbury P.T., Langer R. Synthesis and RGD peptide modification of a new biodegradable copolymer - poly(lactic acid-co-lysine). Journal of the American Chemical Society 1993, 115(23):11010-11011.
8. Cook A.D., Hrkach J.S., Gao N.N., Johnson I.M., Pajvani U.B., Cannizzaro S.M., et al. Characterization and development of RGD-peptide-modified poly(lactic acid-co-lysine) as an interactive, resorbable biomaterial. Journal of Biomedical Materials Research 1997, 35(4):513-523.
9. Tashiro K., Sephel G.C., Weeks B., Sasaki M., Martin G.R., Kleinman H.K., et al. A synthetic peptide containing the Ikvav sequence from the a-chain of laminin mediates cell attachment, migration, and neurite outgrowth. Journal of Biological Chemistry 1989, 264(27):16174-16182.
10. Kibbey M.C., Grant D.S., Kleinman H.K. Role of the SIKVAV site of laminin in promotion of angiogenesis and tumor growth: an in vivo Matrigel model. Journal of the National Cancer Institute 1992, 84(21):1633-1638.
11. Schnaper H.W., Kleinman H.K., Grant D.S. Role of laminin in endothelial cell recognition and differentiation. Kidney International 1993, 43(1):20-25.
12. Charriere G., Bejot M., Schnitzler L., Ville G., Hartmann D.J. Reactions to a bovine collagen implant. Clinical and immunologic study in 705 patients. Journal of the American Academy of Dermatology 1989, 21(6):1203-1208.
13. Sakai D., Mochida J., Iwashina T., Watanabe T., Suyama K., Ando K., et al. Atelocollagen for culture of human nucleus pulposus cells forming nucleus pulposus-like tissue in vitro: influence on the proliferation and proteoglycan production of HNPSV-1 cells. Biomaterials 2006, 27(3):346-353.
14. Ishikawa T., Terai H., Kitajima T. Production of a biologically active epidermal growth factor fusion protein with high collagen affinity. Journal of Biochemistry 2001, 129(4):627-633.
15. Klenkler B.J., Griffith M., Becerril C., West-Mays J.A., Sheardown H. EGF-grafted PDMS surfaces in artificial cornea applications. Biomaterials 2005, 26(35):7286-7296.
16. Boucher C., Ruiz J.C., Thibault M., Buschmann M.D., Wertheimer M.R., Jolicoeur M., et al. Human corneal epithelial cell response to epidermal growth factor tethered via coiled-coil interactions. Biomaterials 2010, 31(27):7021-7031.
17. Kobatake E., Takahashi R., Mie M. Construction of a bFGF-tethered extracellular matrix using a coiled-coil helical interaction. Bioconjugate Chemistry 2011, 22(10):2038-2042.
18. O'Shea E.K., Lumb K.J., Kim P.S. Peptide 'Velcro': design of a heterodimeric coiled coil. Current Biology: CB 1993, 3(10):658-667.
19. O'Shea E.K., Rutkowski R., Stafford W.F., Kim P.S. Preferential heterodimer formation by isolated leucine zippers from fos and jun. Science 1989, 245(4918):646-648.
20. Pepper M.S., Ferrara N., Orci L., Montesano R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochemical and Biophysical Research Communications 1992, 189(2):824-831.
21. Nillesen S.T., Geutjes P.J., Wismans R., Schalkwijk J., Daamen W.F., van Kuppevelt T.H. Increased angiogenesis in acellular scaffolds by combined release of FGF2 and VEGF. Journal of Controlled Release: Official Journal of the Controlled Release Society 2006, 116(2):88-90.
22. Noda T., Kawamura R., Funabashi H., Mie M., Kobatake E. Transduction of NeuroD2 protein induced neural cell differentiation. Journal of Biotechnology 2006, 126(2):230-236.
23. Elloumi I., Kobayashi R., Funabashi H., Mie M., Kobatake E. Construction of epidermal growth factor fusion protein with cell adhesive activity. Biomaterials 2006, 27(18):3451-3458.
24. Holash J., Maisonpierre P.C., Compton D., Boland P., Alexander C.R., Zagzag D., et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999, 284(5422):1994-1998.
25. Zagzag D., Hooper A., Friedlander D.R., Chan W., Holash J., Wiegand S.J., et al. In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis. Experimental Neurology 1999, 159(2):391-400.
26. Bonzon N., Carrat X., Deminiere C., Daculsi G., Lefebvre F., Rabaud M. New artificial connective matrix made of fibrin monomers, elastin peptides and type I + III collagens: structural study, biocompatibility and use as tympanic membranes in rabbit. Biomaterials 1995, 16(11):881-885.
27. Boesen T.P., Soni B., Schwartz T.W., Halkier T. Single-chain vascular endothelial growth factor variant with antagonist activity. The Journal of Biological Chemistry 2002, 277(43):40335-40341.
28. Asahara T., Chen D., Takahashi T., Fujikawa K., Kearney M., Magner M., et al. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circulation Research 1998, 83(3):233-240.
29. Kvanta A., Sarman S., Fagerholm P., Seregard S., Steen B. Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization. Experimental Eye Research 2000, 70(4):419-428.
30. Sakiyama-Elbert S.E., Hubbell J.A. Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix. Journal of Controlled Release: Official Journal of the Controlled Release Society 2000, 69(1):149-158.